NLRP3 and obesity disorder: In this study, we demonstrate that inhibition of NLRP3 inflammasome activity by NLRP3 deletion or injection of MCC950 prevented obesity‐induced cardiac dysfunction, pathological cardiac remodeling, and excessive lipid accumulation.